You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Safety and Efficacy of CD123-Targeted CAR-T Therapy for Relapsed/Refractory Acute Myeloid Leukemia
Recruiting
  • Leukemia
  • +2 more
  • CD123 CAR-T cells
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
2021-03-01
Mar 1, 2021
C
CD123-Targeted CAR-T Cell Therapy for Relapsed/Refractory Acute Myeloid Leukemia
Recruiting
  • Leukemia
  • +2 more
  • CD123 CAR-T cells
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force
2021-03-01
Mar 1, 2021
X
Dual CD33-CLL1-CAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
Not yet recruiting
  • Leukemia, Myeloid, Acute
  • Chongqing, Chongqing, China
    Department of Hematology, Xinqiao Hospital
2021-08-20
Aug 20, 2021
P
Acute Myeloid Leukemia Real World Treatment Patterns
Withdrawn
  • Leukemia, Myeloid, Acute
  • (no location specified)
2021-02-16
Feb 16, 2021
X
Anti-CD33 CAR NK Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
Recruiting
  • Leukemia, Myeloid, Acute
  • anti-CD33 CAR NK cells
  • +2 more
  • Chongqing, Chongqing, China
    Department of Hematology, Xinqiao Hospital
2021-12-22
Dec 22, 2021
W
Investigator Initiated Trial of CPX-351 for Untreated Acute Myeloid Leukemia
Active, not recruiting
  • Leukemia, Myeloid, Acute
  • New York, New York
    Weill Cornell Medical College
2021-12-10
Dec 10, 2021
A
Cardiovascular Function in Acute Leukemia
Enrolling by invitation
  • Leukemia, Myeloid, Acute
  • +2 more
  • observation only
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
2021-03-29
Mar 29, 2021
P
Oral Health Condition and Quality of Life in Children With Leukemia
Recruiting
  • Leukemia, Lymphoblastic
  • Leukemia, Myeloid, Acute
  • This study is observational
  • Bauru, São Paulo, Brazil
    Faculdade de Odontologia de Bauru, Universidade de São Paulo
2021-07-08
Jul 8, 2021
M
Patients Receiving Induction With Liposomal Daunorubicin and Cytarabine (CPX-351) for Acute Myeloid Leukemia
Recruiting
  • Leukemia, Myeloid, Acute
  • Milwaukee, Wisconsin
    Froedtert Hospital
2021-05-24
May 24, 2021
U
Development and Application of a Novel Digital Array PCR for Acute Myeloid Leukemia (AML)
Recruiting
  • Leukemia, Myeloid, Acute
  • Minimal Residual Disease
    • Chapel Hill, North Carolina
      North Carolina Cancer Hospital (NCCH)
    2021-06-08
    Jun 8, 2021
    P
    A Study Of Treatment Patterns And Clinical Outcomes In Patients Diagnosed With Acute Myeloid Leukemia Who Received Mylotarg in the Real-World - 2020
    Completed
    Has Results
    • Leukemia, Myeloid, Acute
    • Gemtuzumab Ozogamicin
    • New York, New York
      Pfizer Investigational Site
    2021-07-16
    Jul 16, 2021
    W
    Prophylactic Application of Donor-derived TCM After Allogeneic HSCT
    Active, not recruiting
    • Leukemia, Myeloid, Acute
    • Myelodysplastic Syndromes
    • TCM allogeneic humane central memory T cells, cryopreserved
    • Wurzburg, Germany
      University Hospital Wuerzburg - Department of Medicine II
    2021-04-07
    Apr 7, 2021
    N
    Pharmacokinetics of Venetoclax in Patients With Acute Myeloid Leukemia
    Recruiting
    • Acute Myeloid Leukemia
    • Taipei, Taiwan
      National Taiwan University Hospital
    2021-10-27
    Oct 27, 2021
    H
    Endogenous Retroviruses in Acute Myeloid Leukemia
    Recruiting
    • Leukemia, Myeloid
    • Demonstration of T cell responses
    • Pierre-Bénite, France
      Hôpital Lyon Sud
    2021-07-26
    Jul 26, 2021
    M
    Flotetuzumab Expanded Access Program
    Available
    • Acute Myeloid Leukemia
    • +2 more
    • flotetuzumab
    • (no location specified)
    2021-08-18
    Aug 18, 2021
    L
    LCI-HEM-SPEC-001: Tissue Collection for Genetic Analysis of Acute Myelogenous Leukemia - 2016
    Completed
    • Leukemia, Myelogenous, Acute
      • Charlotte, North Carolina
        Levine Cancer Institute
      2021-11-05
      Nov 5, 2021
      M
      Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
      Not yet recruiting
      • Acute Myeloid Leukemia
      • +2 more
      • (no location specified)
      2021-08-31
      Aug 31, 2021
      M
      Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML) - 2020
      Completed
      • Leukemia, Myeloid, Acute
      • Liposomal Annamycin
      • La Jolla, California
      • +3 more
      2021-07-12
      Jul 12, 2021
      S
      A Phase 2 Study of Venetoclax in Combination With Low-dose HHT, G-CSF, and AZA as First-line Treatment for Newly Diagnosed Elderly AML Patients Unfit for Intensive Chemotherapy
      Not yet recruiting
      • Leukemia, Myeloid, Acute
      • The combination of HHT, venetoclax, AZA, G-CSF
      • (no location specified)
      2021-03-28
      Mar 28, 2021
      P
      IA14 Induction in Young Acute Myeloid Leukemia
      Recruiting
      • Acute Myeloid Leukemia
      • Idarubicin and cytarabine induction
      • Beijing, Beijing, China
        Xinxin Cao
      2021-06-07
      Jun 7, 2021
      D
      DS-3201b for Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL) - 2021
      Terminated
      • Leukemia, Myeloid, Acute
      • Leukemia, Lymphocytic, Acute
      • Boston, Massachusetts
      • +5 more
      2021-06-11
      Jun 11, 2021
      J
      A Study of Cusatuzumab Plus Azacitidine in Japanese Participants With Newly Diagnosed Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome Who Are Not Candidates for Intensive Treatment - 2021
      Completed
      • Leukemia, Myeloid, Acute
      • Fukushima, Japan
      • +5 more
      2021-12-16
      Dec 16, 2021
      P
      TAA05 Cell Injection in the Treatment of Recurrent / Refractory Acute Myeloid Leukemia
      Recruiting
      • CAR
      • Acute Myeloid Leukemia
      • TAA05 cell injection
      • Hefei, Anhui, China
        Anhui Provincial Hospital
      2021-11-03
      Nov 3, 2021
      U
      ObServatory Children Acute RElated Therapy Leukemia
      Not yet recruiting
      • Leukemia, Myeloid, Acute
      • collection of the clinical and biological characteristics of secondary AMLs in children
      • (no location specified)
      2020-06-29
      Jun 29, 2020
      U
      Evaluation of Measurable Residual Disease in Patients With Acute Myeloid Leukemia as Surrogate Endpoint for Survival
      Recruiting
      • Leukemia, Myeloid, Acute
      • Measurable residual disease measured by flow cytometry
      • Heidelberg, BW, Germany
        University Hospital Heidelberg
      2021-01-04
      Jan 4, 2021